You are viewing the site in preview mode
Skip to main content
|
Cannabis use characteristic
|
Statistic
|
|---|
|
Daily use; n (%)
|
798 (67.7%)
|
|
Age of first cannabis use in years; mean (SD)
|
14.2 (4.5)
|
|
Age at first regular cannabis use in years (defined as use at least twice monthly); mean (SD)
|
16.7 (6.9)
|
|
Self-reported cannabis side effects; n (%)
|
583 (49.5%)
|
|
Type of side effects reported amongst individuals reporting cannabis-related side effectsa; n (%)
| |
|
Sexual problems
|
2 (0.3%)
|
|
Weight gain
|
28 (4.8%)
|
|
Paranoia
|
62 (10.6%)
|
|
Hallucinations
|
10 (1.7%)
|
|
Lack of motivation
|
101 (17.3%)
|
|
Slower thought process
|
153 (26.2%)
|
|
Decreased school/work performance
|
86 (14.8%)
|
|
Other
|
141 (24.2%)
|
|
Marijuana cravings score; mean (SD)
|
37.4 (16.3)
|
|
Self-reported impact of cannabis on MAT
| |
|
No impact
|
881 (74.9%)
|
|
Helps with opioid cravings
|
81 (6.9%)
|
|
Helps with opioid withdrawal symptoms
|
98 (8.3%)
|
|
Helps with MAT dose
|
14 (1.2%)
|
|
Helps with pain management
|
17 (1.4%)
|
|
Increases effect of MAT
|
31 (2.6%)
|
|
Other positive effects
|
82 (7%)
|
|
Worsens OUD symptoms
|
28 (2.4%)
|
|
Unsure
|
15 (1.3%)
|
- SD standard deviation, MAT medication-assisted treatment, OUD opioid use disorder
- aParticipants were able to report only one primary side effect experienced